相关实验视频

Updated: Jan 15, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

在前列腺癌患者中,对[99m Tc]Tc-HYNIC-PSMA单光子发射计算机断层扫描CT进行了回顾性分析

Olof Jonmarker^1,2, Michael Sunderland¹, Lotte Steffens¹

¹Department of Radiology, Christchurch Hospital, Christchurch, New Zealand.

Nuclear medicine communications

|October 8, 2025

概括

[99mTc]Tc-PSMA SPECT/CT显示出作为MRI替代品的前列腺癌分期的承诺. 它提供了与MRI相似的检测速率,特别是在高吸收值的设置中,有助于全面的分期.

科学领域:

核医学是一种核医学.
在瘤学瘤学.
放射学放射学是一门学科.

背景情况:

前列腺癌是男性常见的恶性瘤.
多参数MRI和PSMA PET/CT是目前的分期标准,但可访问性可能是有限的.
[99mTc]Tc-PSMA SPECT/CT正在探索作为一种可访问的分子成像替代方案.

研究的目的:

评估[99mTc]Tc-PSMA SPECT/CT用于前列腺癌分期的诊断性能.
为了比较[99mTc]Tc-PSMA SPECT/CT与MRI和组织病理学.
在资源有限的环境中评估[99mTc]Tc-PSMA SPECT/CT 的实用性.

主要方法:

对82名新诊断的前列腺癌患者进行了回顾性研究.
[99mTc]Tc-PSMA SPECT/CT与MRI的比较和他的病理相关性.
使用12段前列腺模型分析局部分期,并评估转移.
使用类内相关性和科恩的kappa.测量读者之间的协议.

主要成果:

[99mTc]Tc-PSMA SPECT/CT显示了骨转移和横向性的最佳读者间协议.
在基于行业的比较中,PSMA SPECT/CT的检测率与MRI相当.
更高的SPECT标准化吸收值 (SUV) 与活检结果的更强一致性相关.

结论:

[99mTc]Tc-PSMA SPECT/CT是前列腺癌初级诊断的一个有希望的替代方案,特别是在高高的SUV环境中.
虽然MRI对局部延伸更敏感,但PSMA SPECT/CT提供了补充价值.
这种模式在资源有限的环境中,对于全面的分期特别有价值.

关键词:

这就是为什么MRI是MRI.前列腺特异性膜抗原单光子发射计算机断层扫描/计算机断层扫描前列腺癌是前列腺癌.阶段化阶段化

更多相关视频

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET